A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

被引：0
作者：
Aminah Jatoi
Marisa Tria Tirona
Steven S. Cha
Steven R. Alberts
Kendrith M. Rowland
Roscoe F. Morton
Suresh Nair
Carl G. Kardinal
Philip J. Stella
James A. Mailliard
Daniel Sargent
Richard M. Goldberg
机构：
[1] Mayo Clinic and Mayo Foundation,
[2] Saskatchewan Cancer Foundation,undefined
[3] Saskatoon Cancer Centre,undefined
[4] Allan Blair Cancer Centre,undefined
[5] Carle Cancer Center CCOP,undefined
[6] Iowa Oncology Research Association CCOP,undefined
[7] Geisinger Clinic & Medical Center CCOP,undefined
[8] Ochsner CCOP,undefined
[9] Ann Arbor Regional CCOP,undefined
[10] Missouri Valley Cancer Consortium,undefined
来源：
International Journal of Gastrointestinal Cancer | 2002年 / 32卷
关键词：
Docetaxel; Esophageal Cancer; Irinotecan; Topotecan; Esophagogastric Junction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. The incidence of adenocarcinoma of the lower third of the esophagus, esophagogastric junction, and gastric cardia has been rising in the face of limited treatment options for patients with metastatic disease. With the emergence of data to suggest that single agent docetaxel and irinotecan carry antineoplastic effects in this setting, we determined the response rate of these agents when given in combination.
引用
收藏
页码：115 / 123
页数：8
相关论文
共 37 条
  • [1] Pera M(1993)Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction Gastroenterology 104 510-513
  • [2] Cameron AJ(2001)Esophageal cancer. Facts, figures, and screening Gastroenterol Nurs 24 271-273
  • [3] Trastek VF(1999)Outpatient 5-fluorouracil, folic acid, and cisplatin in patients with advanced esophageal carcinoma Acta Oncol 38 255-259
  • [4] Glenn TF(1997)Randomized phase II study of cisplatin and 5-FU versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216-1220
  • [5] Warner E(2002)Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293 Med Oncol 13 87-93
  • [6] Jensen JL(2000)Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity J Clin Oncol 18 116-123
  • [7] Cripps C(1994)Computerized quantitation of synergism and antagonism of Taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: A rational approach to clinical protocol design J Natl Cancer Inst 86 1517-1524
  • [8] Bleiberg H(2002)Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines J Natl Cancer Inst 88 734-741
  • [9] Conroy T(1991)Prospective quality of life analysis after palliative photoablation for the treatment of malignant dysphagia Cancer 68 1660-1664
  • [10] Paillot B(1987)Confidence intervals for a binomial parameter based on multistage tests Biometrics 43 81-93
1234